Abundance of interstitial eosinophils in renal allografts is associated with vascular rejection

Transplantation

Volumn 79, Issue 4, 2005, Pages 444-450

  Meleg Smith, Suzanne ^a,b   Gauthier, Philippe M ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Banff type II rejection; Graft eosinophilia; Iatrogenic interstitial nephritis; Renal allograft nephrectomy; Renal transplantation; Vascular rejection

Indexed keywords

CEPHALOSPORIN; CYCLOSPORIN; DIURETIC AGENT; HYDROCORTISONE; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENOBARBITAL; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; EOSINOPHILIA; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GREAT BLOOD VESSEL; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; IMMUNE COMPLEX NEPHRITIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RECIPIENT; REVIEW; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; EOSINOPHILIA; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 14044260009     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000147318.48620.44     Document Type: Review

References (25)

1. Weir MR, Hall-Craggs M, Shen S-Y, et al. The prognostic value of the eosinophil in acute renal allograft rejection. Transplantation 1986; 41(6): 709.
2. Kormendi F, Amend WJ Jr. The importance of eosinophil cells in kidney allograft rejection. Transplantation 1988; 45(3): 537.
3. Ten RM, Gleich GJ, Holley KE, et al. Eosinophil granule major basic protein in acute renal allograft rejection. Transplantation 1989; 47(6): 959.
4. Hongwei W, Nanra RS, Stein A, et al. Eosinophils in acute renal allograft rejection. Transpl Immunol 1994; 2(1): 41.
5. Racusen LC, Solez K, Colfin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
6. Macdonald FI, Ashraf S, Picton M, et al. Banff criteria as predictors of outcome following acute renal allograft rejection. Nephrol Dial Transplant 1999; 14: 1692.
7. Brenner BM. Brenner and Rector's the kidney. Philadelphia: WB Saunders 2000.
8. Moqbel R, Barkans J, Bradley BL, et al. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy 1992; 22(2): 265.
9. Dosanjh AK, Robinson TE, Strauss J, et al. Eosinophil activation in cardiac and pulmonary acute allograft rejection. J Heart Lung Transplant 1998; 17(10): 1038.
10. Saisu K, Morozumi K, Suzuki K, et al. Significance of interstitial lesions as the early indicator for acute vascular rejection in human renal allografts. Clin Transplant 1999; 13(suppl 1): 17.
11. Kondo T, Marchevsky AM, Jordan SC, et al. Vascular rejection and graft eosinophilia in rat lung allografts. J Surg Res 1991; 51: 310.
12. Nagral A, Ben-Ari Z, Dhillon AP, et al. Eosinophils in acute cellular rejection in liver allografts. Liver Transpl Surg 1998; 4(5): 355.
13. Hallgren R, Bohman SO, Fredens K. Activated eosinophil infiltration and deposits of eosinophil cationic protein in renal allograft rejection. Nephron 1991; 59(2): 266.
14. Nolan CR, Saenz KP, Thomas CA, et al. Role of eosinophil in chronic vascular rejection of renal allografts. Am J Kidney Dis 1995; 26(4): 634.
15. Pattison J, Nelson PJ, Huie P, et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994; 343(8891): 209.
16. Ying S, Meng Q, Taborda-Barata L, et al. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol 1996; 26(1): 70.
17. Young JD, Peterson CG, Venge P, et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986; 321(6070): 613.
18. Makhlouf HR, Drachenberg CB, Trifillis A, et al. Cytotoxic effects of eosinophils on renal proximal tubular epithelial cells: Implications for renal allograft rejection. J Submicrosc Cytol Pathol 1999; 31(4): 533.
19. Trull A, Steel L, Cornelissen J, et al. Association between blood eosinophil counts and acute cardiac and pulmonary allograft rejection. J Heart Lung Transplant 1998; 17(5): 517.
20. Nagral A, Quaglia A, Sabin CA, et al. Blood and graft eosinophils in acute cellular rejection of liver allografts. Transplant Proc 2001; 33(4): 2588.
21. Dollinger MM, Plevris JN, Bouchier IA, et al. Peripheral eosinophil count both before and after liver transplantation predicts acute cellular rejection. Liver Transpl Surg 1997; 3(2): 112.
22. Almirall J, Campistol JM, Sole M, et al. Blood and graft eosinophilia as a rejection index in kidney transplant. Nephron 1993; 65(2): 304.
23. Frenken LA, Leunissen KM, van den Berg-Loonen PM, et al. Blood eosinophilia and renal allograft rejection. Transplant Proc 1987; 19(1 pt 2): 1584.
24. Barnes EJ, Abdel-Rehim MM, Goulis Y, et al. Applications and limitations of blood eosinophilia for the diagnosis of acute cellular rejection in liver transplantation. Am J Transplant 2003; 3(4): 432.
25. Batuman V, Meleg-Smith S. Tubulointerstitial diseases of the kidney. E-Medicine 2001; Available at: www.emedicine.com. Accessed October 2004.